Boule Diagnostics AB

BOUL.ST · Health Technology · Medical Specialties · SE

204 employees · boule.com

About

Boule Diagnostics AB is an internationally active company specializing in the development and production of diagnostics for blood tests. The company was founded in 1975 and is headquartered in Stockholm, Sweden. It has a successful history and has become a leading provider of diagnostics for hematology. Boule Diagnostics AB's business model is based on the development, manufacturing, and sale of automated systems for blood analysis that are used in clinical laboratories and hospitals. Their products offer users precise and fast analysis of blood samples to diagnose diseases such as anemia, leukemia, and other blood disorders. The company also provides solutions for measuring platelet aggregation and hemoglobin. The company is divided into three business areas: hematology, point-of-care, and OEM (Original Equipment Manufacturer). The hematology division is the main business area of Boule Diagnostics AB. The company offers fully automated systems for blood sample analysis that cover a wide range of tests. The hematology product range includes the models DI-60, DI-60E, DI-5, and DI-60s. Each of these analysis machines offers high accuracy and precision in blood sample analysis, reliably supporting the work of medical personnel in laboratories and hospitals. Point of Care is another business division of Boule Diagnostics AB. It offers products for the rapid diagnosis and monitoring of patients at the point of care. This includes the Vidas® Pro point-of-care system, which provides many features of a full-fledged hematology analyzer in a compact size. Lastly, Boule Diagnostics AB also offers OEM solutions for companies that want to develop and manufacture their own diagnostic systems. Boule Diagnostics AB places great importance on the quality of its products and services. The company is ISO 13485 certified, meaning that all products from Boule Diagnostics AB comply with European and international quality standards. Furthermore, Boule Diagnostics AB strives to educate customers on the use of its products and services to ensure high-quality clinical diagnostics and safe laboratory work. Overall, Boule Diagnostics AB offers its customers automated diagnostic systems for hematology and point-of-care with high quality and accuracy. The company is a reliable partner for laboratories and hospitals. The product lines DI-60, DI-60E, DI-5, and DI-60s for hematology, and Vidas® Pro for point-of-care, are widely recognized worldwide and have proven themselves in clinical practice.

Annual results

Reported figures, SEK · revenue down 12.4% in 2025

YearRevenueNet incomeNet marginFree cash flow
2025489M-3.0M-0.6%—
2024558M-223M-40.0%—
2023571M24.0M4.2%—
2022548M12.0M2.2%—
2021463M23.0M5.0%—

Dividends per share

2022 0.39 SEK2021 0.39 SEK2019 0.39 SEK2018 0.50 SEK2017 0.35 SEK

BOUL.ST in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Boule Diagnostics AB are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Boule Diagnostics AB (BOUL.ST) — company profile and financials · MarketPulse